4.7 Review

The present status of metformin in fertility-preserving treatment in atypical endometrial hyperplasia and endometrioid endometrial cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

Low-dose metformin targets the lysosomal AMPK pathway through PEN2

Teng Ma et al.

Summary: The molecular target of the antidiabetic medicine metformin is identified as PEN2, and the PEN2-ATP6AP1 axis activates the AMPK pathway, providing therapeutic effects without substantial adverse effects.

NATURE (2022)

Article Oncology

Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: Results of a randomized clinical trial

Monika Janda et al.

Summary: This study examined the effectiveness of using LNG-IUD combined with M or WL in patients with EAC or EHA, and found that the pCR rates were high in all three groups at 6 months.

GYNECOLOGIC ONCOLOGY (2021)

Review Oncology

Metformin as a Therapeutic Target in Endometrial Cancers

Teresa Y. Lee et al.

FRONTIERS IN ONCOLOGY (2018)

Review Obstetrics & Gynecology

Endometrial preparation with Dienogest before hysteroscopic surgery: a systematic review

Antonio Simone Lagana et al.

ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2017)

Review Oncology

Effects of metformin on endometrial cancer: Systematic review and meta-analysis

Cinthia G. Meireles et al.

GYNECOLOGIC ONCOLOGY (2017)

Article Oncology

Measuring the biological effect of presurgical metformin treatment in endometrial cancer

V. N. Sivalingam et al.

BRITISH JOURNAL OF CANCER (2016)

Article Oncology

Metformin use and endometrial cancer survival

Nicole S. Nevadunsky et al.

GYNECOLOGIC ONCOLOGY (2014)

Editorial Material Medicine, General & Internal

The Target of Metformin in Type 2 Diabetes

Ele Ferrannini

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Oncology

Metformin Reverses Progestin Resistance in Endometrial Cancer Cells by Downregulating GloI Expression

Zhenbo Zhang et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2011)

Article Biochemistry & Molecular Biology

Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells

Ya Xie et al.

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2011)